Blood transfusions are a life-saving medical procedure, but they can also be dangerous. The ABO system of blood typing is the most important factor to consider when matching donor and recipient blood. ABO incompatibility can cause severe reactions and even death. This article will explore the complexities of ABO incompatibility and provide a guide to understanding blood type compatibility.
ABO incompatibility is a type of transfusion reaction that occurs when a donor’s blood is incompatible with the recipient’s. The ABO system is the most important factor to consider when matching donor and recipient blood. It is based on the presence or absence of A and B antigens on the surface of red blood cells. A person’s blood type is determined by the combination of antigens present. There are four blood types: A, B, AB, and O. Type A blood has A antigens, type B has B antigens, type AB has both A and B antigens, and type O has neither. A person’s blood type is determined by the combination of antigens present. When a person receives a transfusion of incompatible blood, their body will recognize the foreign antigens and produce antibodies to attack them. This can cause a severe reaction, and in some cases, death.
In order to determine blood type compatibility, the donor and recipient must both be tested for their ABO type. This is done by taking a sample of blood and testing it for the presence of A and B antigens. The ABO system is based on the principle of “like dissolves like.” This means that if a person has type A blood, they can only receive type A or type O blood. If a person has type B blood, they can only receive type B or type O blood. If a person has type AB blood, they can receive any type of blood. And if a person has type O blood, they can only receive type O blood.
ABO incompatibility can cause a number of serious complications, including anaphylactic shock, hemolytic anemia, and acute renal failure. Anaphylactic shock is a life-threatening reaction that can occur within minutes of a transfusion. Symptoms include difficulty breathing, hives, and swelling of the face, lips, and throat. Hemolytic anemia is a condition in which the body destroys its own red blood cells. This can lead to a decrease in oxygen-carrying capacity, fatigue, and jaundice. Acute renal failure is a condition in which the kidneys suddenly stop working properly. Symptoms include nausea, vomiting, and decreased urine output.
The best way to prevent ABO incompatibility is to ensure that the donor and recipient have compatible blood types. This can be done by performing a blood test and cross-matching the donor and recipient’s blood. The cross-matching process involves mixing a sample of the donor’s blood with a sample of the recipient’s blood to check for compatibility. It is also important to use the correct type of blood for transfusion. Type O-negative is the universal donor type, meaning it can be safely given to any recipient. Type AB-positive is the universal recipient type, meaning it can receive any type of blood.
ABO incompatibility is a serious complication of blood transfusions that can lead to life-threatening reactions. It is important to understand the complexities of ABO incompatibility and how to determine blood type compatibility. By understanding the ABO system and performing the necessary tests, it is possible to prevent ABO incompatibility and ensure the safety of the donor and recipient.
1.
The way that miR-377 inhibits cells that cause prostate cancer.
2.
Five new papers highlight cancer inequities, challenges and opportunities in South Asia
3.
The standard for high-risk prostate cancer is supported by a study using high-dose RT and long-term ADT.
4.
What Dolph Lundgren's journey from terminal diagnosis to 'cancer free' can tell us about cancer care
5.
Survivors of childhood brain cancer are more likely to be held back in school
1.
Precision Era in Pediatric Oncology, from Genomic Breakthroughs to Lifelong Learning
2.
Fibroma: Understanding the Causes, Symptoms, and Treatment Options
3.
Navigating the Evolving Landscape of Oncology Clinical Trials in the Era of Precision Medicine
4.
The Importance of Early Detection in Angiosarcoma: A Story of Survival
5.
Impact of Hormone Therapy Cessation on Tumor Growth: Case Study of Ki-67 Reduction
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
4.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation